FDA advisers endorse new RSV antibody drug for babies

By NPR
| June 09, 2023

FDA advisers recommend the approval a new antibody drug to protect infants from serious lung illnesses caused by RSV.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...